Ravid, Jonathan D.
Laffin, Luke J. http://orcid.org/0000-0002-3262-792X
Article History
Accepted: 14 July 2022
First Online: 4 August 2022
Declarations
:
: Jonathan D. Ravid has no disclosures to report. Luke J. Laffin reports grants to his institution from AstraZeneca and Mineralys Therapeutics; Royalties or licenses from Belvoir Media Group and Elsevier; Consulting fees from Medtronic; Payment or honoraria from Cardiometabolic Health Congress; Participation on a Data Safety Monitoring board or Advisory board for Crispr Therapeutics and Eli Lilly Pharmaceuticals; and Stock or stock options for LucidAct Health and Gordy Health.
: This article does not contain any studies with human or animal subjects performed by any of the authors.